It reduces downstream AKT activity and, consequently, its partial or complete loss of function activates the PI3K-AKT pathway, causing a dysregulation in cell cycle control, apoptosis, cell contact and migration in different cancers [24]. The gene discussed is AKT1; the disease is cancer.